93-00-5

应用筛选条件

关键词:'93-00-5'

显示 1-5 共 5 条结果关于 "93-00-5" 范围论文

Improved method for the extraction and chromatographic analysis on a fused-core column of ellagitannins found in oak-aged wine.

María Navarro et al.

Food chemistry, 226, 23-31 (2017-03-04)

A new method for the analysis of ellagitannins observed in oak-aged wine is proposed, exhibiting interesting advantages with regard to previously reported analytical methods. The necessary extraction of ellagitannins from wine was simplified to a single step of solid phase

Role of bound zinc in dimer stabilization but not enzyme activity of neuronal nitric-oxide synthase.

B Hemmens et al.

The Journal of biological chemistry, 275(46), 35786-35791 (2000-08-24)

Nitric-oxide synthases (NOS) are homodimeric proteins and can form an intersubunit Zn(4S) cluster. We have measured zinc bound to NOS purified from pig brain (0.6 mol/mol of NOS) and baculovirus-expressed rat neuronal NOS (nNOS) (0.49 +/- 0.13 mol/mol of NOS)

Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.

Sanjit S Jolly et al.

Lancet (London, England), 387(10014), 127-135 (2015-10-18)

Two large trials have reported contradictory results at 1 year after thrombus aspiration in ST elevation myocardial infarction (STEMI). In a 1-year follow-up of the largest randomised trial of thrombus aspiration, we aimed to clarify the longer-term benefits, to help

Associations between androgens and sexual function in premenopausal women: a cross-sectional study.

Jia Zheng et al.

The lancet. Diabetes & endocrinology, 8(8), 693-702 (2020-07-25)

Although clinicians often measure the serum concentration of androgens in premenopausal women presenting with sexual dysfunction, with some women given testosterone or dehydroepiandrosterone as treatment if their concentrations are low, whether androgens are determinants of sexual function in women of

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

Annemiek Broyl et al.

The Lancet. Oncology, 11(11), 1057-1065 (2010-09-25)

Bortezomib-induced peripheral neuropathy is a dose-limiting toxicity in patients with multiple myeloma, often requiring adjustment of treatment and affecting quality of life. We investigated the molecular profiles of early-onset (within one treatment cycle) versus late-onset (after two or three treatment

1/1